TapImmune Inc.
2815 Eastlake Avenue East
Suite 300
Seattle
Washington
98102
United States
Tel: 866-359-7541
Website: http://www.tapimmune.com/
Email: ir@TapImmune.com
161 articles about TapImmune Inc.
-
TapImmune Inc. Presents New Data At San Antonio Breast Cancer Symposium Showing Robust Generation Of T-Cell Immunity
12/10/2015
-
FDA Grants Orphan Drug Designation To TapImmune Inc.'s TPIV 200 In The Treatment Of Ovarian Cancer
12/10/2015
-
TapImmune Inc. To Present New Data At San Antonio Breast Cancer Symposium On December 10, 2015
12/7/2015
-
TapImmune Inc. To Present At LD Micro Main Event On December 1, 2015
11/30/2015
-
Immuno-Oncology Company, TapImmune Inc., Moves Corporate Headquarters To Jacksonville Florida
11/5/2015
-
TapImmune Inc. To Present At Dawson James Small Cap Growth Conference In Florida On October 15, 2015
10/13/2015
-
TapImmune Inc. To Present At Aegis Capital 2015 Growth Conference In Las Vegas On October 9, 2015
10/7/2015
-
TapImmune Inc. Vaccine To Be Studied In A $13.3 Million U.S. Department Of Defense Grant To Mayo Clinic For Phase II Clinical Trial In Triple Negative Breast Cancer
9/15/2015
-
TapImmune Inc. To Provide Update On And Confirmation Of Phase II Clinic Trial Initiation
9/10/2015
-
TapImmune Inc. To Present At The SeeThruEquities Fall
9/8/2015
-
TapImmune Inc. To Present At 17th Annual Rodman & Renshaw Healthcare Conference
9/2/2015
-
TapImmune Inc. Completes Transfer of IND From The Mayo Clinic
8/18/2015
-
TapImmune Inc. Appoints John N. Bonfiglio, Ph.D., To Its Board Of Directors
7/30/2015
-
TapImmune Inc. Announces Finalization Of License Agreement With Mayo Clinic To Commercialize A Folate Receptor Alpha Vaccine For Multiple Cancer Indications
7/27/2015
-
TapImmune Inc. Reports Robust Immune Responses Generated In 19 Of 20 Evaluable HER2/Neu Breast Cancer Patients
6/23/2015
-
TapImmune Inc. Announces Immediate Infusion of $2.5 Million Dollars From Largest Institutional Investor
6/19/2015
-
TapImmune Inc. Announces Agreement To Facilitate Near Term Capital Infusion; Expediting Path Toward Phase II Trial Initiation
6/3/2015
-
TapImmune Inc. To Present Clinical & Scientific Update At The 2015 Marcum Microcap Conference
5/20/2015
-
TapImmune Inc. Release: Phase I Study In Ovarian & Breast Cancer Published In Abstracts Of 2015 ASCO Annual Meeting
5/15/2015
-
TapImmune Inc. Release: Despite Unimpressive Company Guidance Shares Soar - BrokerBank Securities
5/13/2015